India's evolving pharma policies—NPPA price controls, DPCO, NLEM—impact profitability. Strategies include portfolio diversification, rural market focus, leveraging PLI, Ayushman Bharat, Jan Aushadhi, margin rationalization, GST awareness, and digital health compliance for growth.